GSRF
NASDAQ · N/A
Gsr Iv Acquisition Corp-Cl A
$10.16
+0.01 (+0.05%)
Open$10.16
Previous Close$10.16
Day High$10.16
Day Low$10.16
52W High$10.20
52W Low$9.96
Volume—
Avg Volume79.9K
Market Cap298.76M
P/E Ratio74.39
EPS$0.14
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 146.09M | 153.79M | 147.45M |
| Net Income | 10.19M | 14.28M | 11.11M |
| Profit Margin | 7.0% | 9.3% | 7.5% |
| EBITDA | 17.65M | 19.50M | 17.14M |
| Free Cash Flow | 14.65M | 14.16M | 16.41M |
| Rev Growth | +20.6% | +16.4% | -5.4% |
| Debt/Equity | 0.07 | 0.10 | 0.08 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.07 | -1.51% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |